AEON stock news · AEON Biopharma

Stories about AEON Biopharma (AEON) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for AEON

Follow AEON Biopharma (AEON) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Oct 2, 2026, 5:12 PM ET · Market
On Friday evening, 12 health care stocks saw big changes in their prices.
Neutral
AEON Biopharma's shares fell about 6% after hours, but the report gives no company news to change its business outlook.
Sep 30, 2026, 1:17 PM ET · Market
12 health care companies are seeing big changes in their stock prices today.
Neutral
AEON Biopharma shares rose 21% to $0.31. The article gives no company news explaining the move, so it does not change the business outlook.
Sep 30, 2026, 8:10 AM ET · Trial
AEON Biopharma, Inc. shares news about FDA's feedback on its biosimilar product ABP-450.
Good for AEON
AEON received FDA meeting minutes that support its proposed study plan for ABP-450. This moves the Botox biosimilar program forward, but more evidence and FDA decisions remain.